Genmab | GEN - Devedores Comerciais

Preço das Ações
1,743.50
Mudança Diária
-32.00 -1.80%
Mensal
5.73%
Anual
30.11%
Q2 Previsão
1,715.96




Devedores Comerciais Alterar Data
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Almirall EUR 175.93M 17.87M 2025-12
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.57B 1.08B 2025-12
argenx SE USD 1.2B 289.13M 2025-06
AstraZeneca USD 19.05B 1.49B 2025-12
Bayer EUR 14.19B 720M 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Demant DKK 5.5B 262M 2025-12
Exelixis USD 286.92M 24.38M 2025-12
Fresenius Medical Care EUR 3.66B 382.33M 2025-12
Galapagos EUR 199.75M 122.08M 2025-12
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
GN Store Nord DKK 5.29B 100M 2025-12
GRIFOLS EUR 852M 244.52M 2025-12
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.44B 293M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 100M 2025-12
UCB EUR 1.97B 54M 2025-12